Suppr超能文献

DNA连接酶IV通过位于其BRCT结构域之间而非内部的一个基序与XRCC4结合。

DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains.

作者信息

Grawunder U, Zimmer D, Lieber M R

机构信息

University of Southern California School of Medicine, Norris Comprehensive Cancer Center, Department of Pathology, Los Angeles 90033, USA.

出版信息

Curr Biol. 1998 Jul 16;8(15):873-6. doi: 10.1016/s0960-9822(07)00349-1.

Abstract

The covalent rejoining of DNA ends at single-stranded or double-stranded DNA breaks is catalyzed by DNA ligases. Four DNA ligase activities (I-IV) have been identified in mammalian cells [1]. It has recently been demonstrated that DNA ligase IV interacts with and is catalytically stimulated by the XRCC4 protein [2,3], which is essential for DNA double-strand break repair and the genomic rearrangement process of V(D)J recombination [4]. Together with the finding that the yeast DNA ligase IV homologue is essential for nonhomologous DNA end joining [5-7], this has led to the hypothesis that mammalian DNA ligase IV catalyzes ligation steps in both of these processes [8]. DNA ligase IV is characterized by a unique carboxy-terminal tail comprising two BRCT (BRCA1 carboxyl terminus) domains. BRCT domains were initially identified in the breast cancer susceptibility protein BRCA1 [9], but are also found in other DNA repair proteins [10]. It has been suggested that DNA ligase IV associates with XRCC4 via its tandem BRCT domains and that this may be a general model for protein-protein interactions between DNA repair proteins [3]. We have performed a detailed deletional analysis of DNA ligase IV to define its XRCC4-binding domain and to characterize regions essential for its catalytic activity. We find that a region in the carboxy-terminal tail of DNA ligase IV located between rather than within BRCT domains is necessary and sufficient to confer binding to XRCC4. The catalytic activity of DNA ligase IV is affected by mutations within the first two-thirds of the protein including a 67 amino-acid amino-terminal region that was previously thought not to be present in human DNA ligase IV [11].

摘要

DNA连接酶催化单链或双链DNA断裂处DNA末端的共价重连。在哺乳动物细胞中已鉴定出四种DNA连接酶活性(I-IV)[1]。最近已证明,DNA连接酶IV与XRCC4蛋白相互作用并受到其催化刺激[2,3],XRCC4蛋白对于DNA双链断裂修复和V(D)J重组的基因组重排过程至关重要[4]。结合酵母DNA连接酶IV同源物对非同源DNA末端连接必不可少这一发现[5-7],这导致了一种假设,即哺乳动物DNA连接酶IV在这两个过程中均催化连接步骤[8]。DNA连接酶IV的特征是具有一个独特的羧基末端尾巴,该尾巴包含两个BRCT(BRCA1羧基末端)结构域。BRCT结构域最初是在乳腺癌易感蛋白BRCA1中鉴定出来的[9],但在其他DNA修复蛋白中也有发现[10]。有人提出,DNA连接酶IV通过其串联的BRCT结构域与XRCC4结合,这可能是DNA修复蛋白之间蛋白质-蛋白质相互作用的通用模型[3]。我们对DNA连接酶IV进行了详细的缺失分析,以确定其XRCC4结合结构域并表征其催化活性所必需的区域。我们发现,DNA连接酶IV羧基末端尾巴中位于BRCT结构域之间而非内部的一个区域对于赋予与XRCC4的结合是必要且充分的。DNA连接酶IV的催化活性受到该蛋白前三分之二区域内突变的影响,包括一个先前认为不存在于人类DNA连接酶IV中的67个氨基酸的氨基末端区域[11]。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验